Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
This table outlines the considerations and steps involved in using oral isotretinoin for severe acne treatment, emphasizing the importance of patient education, monitoring, and safety precautions. This is based on NICE recommendations.
| Oral Isotretinoin Treatment |
|---|
| Consideration Criteria |
| - Age: > 12 years |
| - Severe acne resistant to standard therapy with systemic antibiotics and topical treatment, including but not limited to: |
| - Nodulo-cystic acne |
| - Acne conglobata |
| - Acne fulminans |
| - Acne at risk of permanent scarring |
| MHRA Guidance Follow-Up |
| - Prescribe only by a consultant dermatologist-led team |
| - Assess and monitor mental health |
| - Assess and monitor sexual function |
| Informed Consent and Information |
| - Fully inform the patient (and their family/carers if needed) about potential risks and benefits before referral to the consultant-dermatologist-led team and before prescribing isotretinoin if chosen. |
| Psychological Wellbeing |
| - Consider the patient's psychological wellbeing and refer to mental health services before starting treatment if appropriate. |
| Potential Pregnancy |
| - If pregnancy potential exists: |
| - Explain the risk to a developing baby if isotretinoin is taken during pregnancy |
| - Inform them about following the MHRA pregnancy prevention program |
| Dosage |
| - Prescribe isotretinoin for acne treatment at a standard daily dose of 0.5 to 1 mg/kg. |
| - Consider... |
Try our Free Plan to get the full article.
